Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 4
2010 7
2011 7
2012 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
The role of microRNA in human lung squamous cell carcinoma.
Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, Ma Q, Wang YJ. Yang Y, et al. Cancer Genet Cytogenet. 2010 Jul 15;200(2):127-33. doi: 10.1016/j.cancergencyto.2010.03.014. Cancer Genet Cytogenet. 2010. PMID: 20620595
Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
Tanaka N, Toyooka S, Soh J, Kubo T, Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, Asano H, Tsukuda K, Aoe K, Miyoshi S. Tanaka N, et al. Lung Cancer. 2012 Apr;76(1):32-8. doi: 10.1016/j.lungcan.2011.10.002. Epub 2011 Nov 1. Lung Cancer. 2012. PMID: 22047961 Free article.
MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y, Giaccone G. Lee JH, et al. PLoS One. 2011;6(6):e21300. doi: 10.1371/journal.pone.0021300. Epub 2011 Jun 22. PLoS One. 2011. PMID: 21731696 Free PMC article.
DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.
Wang Z, Chen Z, Gao Y, Li N, Li B, Tan F, Tan X, Lu N, Sun Y, Sun J, Sun N, He J. Wang Z, et al. Cancer Biol Ther. 2011 Mar 1;11(5):490-6. doi: 10.4161/cbt.11.5.14550. Cancer Biol Ther. 2011. PMID: 21383543
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM. Garofalo M, et al. Nat Med. 2011 Dec 11;18(1):74-82. doi: 10.1038/nm.2577. Nat Med. 2011. PMID: 22157681 Free PMC article.
Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.
Xie L, Chen X, Wang L, Qian X, Wang T, Wei J, Yu L, Ding Y, Zhang C, Liu B. Xie L, et al. BMC Cancer. 2010 Oct 28;10:591. doi: 10.1186/1471-2407-10-591. BMC Cancer. 2010. PMID: 21029414 Free PMC article.
MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B, Wang R, Chen LB. Feng B, et al. Cancer Lett. 2012 Apr 28;317(2):184-91. doi: 10.1016/j.canlet.2011.11.024. Epub 2011 Nov 25. Cancer Lett. 2012. PMID: 22120675
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.
Crawford M, Batte K, Yu L, Wu X, Nuovo GJ, Marsh CB, Otterson GA, Nana-Sinkam SP. Crawford M, et al. Biochem Biophys Res Commun. 2009 Oct 23;388(3):483-9. doi: 10.1016/j.bbrc.2009.07.143. Epub 2009 Aug 3. Biochem Biophys Res Commun. 2009. PMID: 19654003 Free PMC article.
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.
Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K, Andersen S, Stenvold H, Al-Shibli K, Al-Saad S, Bremnes RM, Busund LT. Donnem T, et al. PLoS One. 2012;7(1):e29671. doi: 10.1371/journal.pone.0029671. Epub 2012 Jan 25. PLoS One. 2012. PMID: 22295063 Free PMC article.
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG. Wiggins JF, et al. Cancer Res. 2010 Jul 15;70(14):5923-30. doi: 10.1158/0008-5472.CAN-10-0655. Epub 2010 Jun 22. Cancer Res. 2010. PMID: 20570894 Free PMC article.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page